PRE PRENETICS GLOBAL LIMITED

Prenetics to Participate in the 37th Annual ROTH Conference

Prenetics to Participate in the 37th Annual ROTH Conference

CHARLOTTE, N.C., March 11, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading consumer health sciences company, announced today the Company will participate in the 37th Annual ROTH Conference being held Sunday, March 16th to Tuesday, March 18th at the Laguna Cliffs Marriott Resort in Dana Point, CA.

Prenetics’ Chief Executive Officer Danny Yeung and President of Americas David Vanderveen will be available to host one-on-one meetings with investors during the event. In addition, management will participate in a panel discussion on Longevity and Supplementation on Monday, March 17th at 12:00pm PT. Interested parties may access the panel through the webcast link which will also be posted to Prenetics’ investor relations website .

To schedule a one-on-one meeting with Prenetics’ management, please contact Investor Relations at or your ROTH representative.

About Prenetics

Prenetics (NASDAQ:PRE), a leading health sciences company, is dedicated to advancing consumer and clinical health. Our consumer initiative is led by IM8, a new health and wellness brand, and Europa, one of the largest sports distribution companies in the USA. Our clinical division is led by Insighta, our $200 million venture focused on multi-cancer early detection technologies. Each of Prenetics’ units synergistically enhances our global impact on health, embodying our commitment to ‘enhancing life through science’. To learn more about Prenetics, please visit prenetics.com.

Investor Relations Contact:



Angela Cheung

Investor Relations / Corporate Finance

Prenetics Global Limited



EN
11/03/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PRENETICS GLOBAL LIMITED

 PRESS RELEASE

Prenetics’ IM8 Health Expands Scientific Advisory Board, Reinforcing C...

Prenetics’ IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements Market Adds Renowned Clinical Experts Dr. Jeremy London and Dr. Amy Shah to Existing Team from Mayo Clinic, Cedars-Sinai, NASA and Yale University CHARLOTTE, N.C., March 18, 2025 (GLOBE NEWSWIRE) --  , the premium supplements brand co-founded by David Beckham, today announced the addition of two distinguished new members, Dr. Jeremy London and Dr. Amy Shah, to its world-class (SAB). These additions underscore IM8’s unwavering commitment to leading innovation in science, lo...

 PRESS RELEASE

Prenetics to Participate in the 37th Annual ROTH Conference

Prenetics to Participate in the 37th Annual ROTH Conference CHARLOTTE, N.C., March 11, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading consumer health sciences company, announced today the Company will participate in the 37th Annual ROTH Conference being held Sunday, March 16th to Tuesday, March 18th at the Laguna Cliffs Marriott Resort in Dana Point, CA. Prenetics’ Chief Executive Officer Danny Yeung and President of Americas David Vanderveen will be available to host one-on-one meetings with investors during the event. In addition, management will participate...

 PRESS RELEASE

Prenetics Announces Fourth Quarter and Full Year 2024 Financial Result...

Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance Revenue grew 93.5% to $10.5 million in the fourth quarter and 40.9% year-over-year to $30.6 million in 2024 Cash and short-term assets of $84.8 million as of December 31, 2024 Provides first quarter and full year 2025 guidance Projects full year 2025 revenue of $73 million to $85 million, driven by the strong launch of CHARLOTTE, N.C., March 05, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences ...

 PRESS RELEASE

Nasdaq-Listed Prenetics Announces Genomics-Based Partnership with Huma...

Nasdaq-Listed Prenetics Announces Genomics-Based Partnership with Humanity Protocol and Launches Crypto Strategic Reserve CircleDNA powers blockchain-based identity verification with Humanity Protocol, valued at US $1.1bn after latest fundraisePrenetics invests $1.5M in Bitcoin, Solana and H tokens, supported by strong balance sheetPrenetics advances Decentralized Science (DeSci) with AI-driven early cancer detection, backed by $30M investment from Tencent CHARLOTTE, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading genomics and consumer healthcare...

 PRESS RELEASE

Prenetics Unveils IM8 to U.S. Consumers with Co-Founding Partner David...

Prenetics Unveils IM8 to U.S. Consumers with Co-Founding Partner David Beckham The Next Big Thing in Wellness? IM8 Lands in the U.S. with a Star-Studded Launch. David Beckham and a world-class scientific team are putting the focus back on foundational health CHARLOTTE, N.C., Jan. 21, 2025 (GLOBE NEWSWIRE) -- , a premium supplements brand co-founded by David Beckham, hosted its U.S. unveiling event in New York City on January 14. The two-part event featured an Inside Out Wellness session with holistic health advocate Deepak Chopra, M.D., and David Beckham, followed by An Evening with IM8 ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch